Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114673 · ClinicalTrials.gov registry record
A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling
A clinical trial of Skin Wrinkling, sponsored by Graceway Pharmaceuticals.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT00114673 is a study of Skin Wrinkling that has completed, run by Graceway Pharmaceuticals. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00114673, a study of Skin Wrinkling, has completed, sponsored by Graceway Pharmaceuticals.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Skin chronically exposed to the sun may become damaged and then develop wrinkles and/or uneven skin color. The purpose of this research study is to evaluate a newly developed scale (grading tool) that rates wrinkles and uneven skin color. This newly developed scale will be used in future topical drug studies to measure these changes in the skin.
Conditions Studied
Study Locations (1)
Massachusetts
- - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00114673
The ClinicalTrials.gov registry entry for NCT00114673 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Graceway Pharmaceuticals, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Wrinkling appearing as the primary indexed condition, and to 0 interventions.
NCT00114673 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00114673 about?
NCT00114673 is a clinical study titled "A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling". Skin chronically exposed to the sun may become damaged and then develop wrinkles and/or uneven skin color. The purpose of this research study is to evaluate a newly developed scale (grading tool) that rates wrinkles and uneven skin color. This newly developed scale will be used in future topical dru...
What is the current status of trial NCT00114673?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2005-06.
What conditions does trial NCT00114673 study?
This clinical trial studies the following conditions: Skin Wrinkling.
Who is sponsoring clinical trial NCT00114673?
This trial is sponsored by Graceway Pharmaceuticals, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00114673 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.